Lowe's To Rally Around 19%? Here Are 10 Other Price Target Changes For Thursday
Lowe's To Rally Around 19%? Here Are 10 Other Price Target Changes For Thursday
羅氏反彈在 19% 左右?這是星期四的 10 個其他目標價格變化
- Goldman Sachs raised Lowe's Companies, Inc. (NYSE:LOW) price target from $241 to $246. . Goldman Sachs analyst Kate McShane maintained a Buy rating on the stock. Lowe's shares fell 0.1% to $206.70 in pre-market trading.
- Stephens & Co. boosted NCR Corporation (NYSE:NCR) price target from $28 to $32. Stephens & Co. analyst Charles Nabhan maintained an Overweight rating on the stock. NCR rose 0.3% to close at $22.87 on Wednesday.
- Credit Suisse raised the price target on Campbell Soup Company (NYSE:CPB) from $52 to $54. Credit Suisse analyst Robert Moskow maintained a Neutral rating on the stock. Campbell Soup shares fell 0.1% to $56.11 in pre-market trading.
- Raymond James cut GDS Holdings Limited (NASDAQ:GDS) price target from $55 to $35. Raymond James analyst Frank Louthan maintained an Outperform rating on the stock. GDS Holdings shares rose 7.6% to $18.89 in pre-market trading.
- JP Morgan cut Martin Marietta Materials, Inc. (NYSE:MLM) price target from $410 to $395. JP Morgan analyst Adrian Heurta maintained an Overweight rating on the stock. Martin Marietta Materials shares gained 0.7% to close at $352.50 on Wednesday.
- BTIG boosted Prometheus Biosciences, Inc. (NASDAQ:RXDX) price target from $74 to $181. BTIG analyst Julian Harrison maintained a Buy rating on the stock. Prometheus Biosciences shares jumped 9.4% to $104.84 in pre-market trading.
- Oppenheimer cut Mirati Therapeutics, Inc. (NASDAQ:MRTX) price target from $85 to $60. Oppenheimer analyst Jay Olson maintained the stock with a Perform. Mirati Therapeutics Limited shares fell 0.2% to $49.47 in pre-market trading.
- HC Wainwright & Co. cut Gossamer Bio, Inc. (NASDAQ:GOSS) price target from $25 to $5. Gold HC Wainwright & Co. analyst Patrick Trucchio maintained a Buy rating on the stock. Gossamer Bio shares fell 1.8% to $2.12 in pre-market trading.
- Baird cut Salesforce, Inc. (NYSE:CRM) price target from $200 to $150. Baird analyst Rob Oliver downgraded the stock from Outperform to Neutral. Salesforce shares fell 0.9% to $129.37 in pre-market trading.
- Jefferies cut Lumos Pharma, Inc. (NASDAQ:LUMO) price target from $17 to $7. Jefferies analyst Eun Yang downgraded the stock from Buy to Hold. Lumos Pharma shares fell 11.2% to close at $4.46 on Wednesday.
- UBS boosted The Hershey Company (NYSE:HSY) price target from $244 to $269. UBS analyst Cody Ross upgraded the stock from Neutral to Buy. Hershey shares rose 1.2% to $239.61 in pre-market trading.
- 高盛募集資金勞氏公司。(紐約證券交易所：低價)目標從241美元降至246美元。。高盛分析師凱特·麥克肖恩維持對該股的買入評級。在盤前交易中，勞氏股價下跌0.1%，至206.70美元。
- 斯蒂芬斯公司股價上漲NCR公司(紐約證券交易所代碼：NCR)目標價從28美元降至32美元。Stephens&Co.分析師納布漢(Charles Nabhan)對該股維持增持評級。NCR週三上漲0.3%，收報22.87美元。
- 瑞士信貸上調了目標價金寶湯公司(紐約證券交易所代碼：CPB)從52美元升至54美元。瑞士信貸分析師羅伯特·莫斯科夫對該股維持中性評級。在盤前交易中，Campbell Soup股價下跌0.1%，至56.11美元。
- 雷蒙德·詹姆斯·卡特爾萬國數據(納斯達克代碼：GDS)目標價從55美元降至35美元。Raymond James分析師Frank Louthan對該股維持表現優於大盤的評級。在盤前交易中，萬國數據的股價上漲了7.6%，至每股18.89美元。
- 摩根大通降息馬丁·瑪麗埃塔材料公司(紐約證券交易所代碼：MLM)目標價從410美元降至395美元。摩根大通分析師禤浩焯·赫爾塔維持對該股的增持評級。馬丁·瑪麗埃塔材料公司股價週三上漲0.7%，收於352.50美元。
- BTIG得到提振普羅米修斯生物科學公司(納斯達克：RXDX)目標價從74美元降至181美元。BTIG分析師朱利安·哈裡森對該股維持買入評級。在盤前交易中，普羅米修斯生物科學公司的股價躍升9.4%，至104.84美元。
- 奧本海默切割米拉蒂治療公司(納斯達克：MRTX)目標價從85美元降至60美元。奧本海默分析師傑伊·奧爾森維持了該股的表現。在盤前交易中，Mirati Treateutics Limited的股價下跌0.2%，至49.47美元。
- HC Wainwright&Co.Cut薄荷生物股份有限公司(納斯達克代碼：戈斯)目標價從25美元降至5美元。Gold HC Wainwright&Co.分析師帕特裡克·楚奇奧維持對該股的買入評級。在盤前交易中，Gossamer Bio股價下跌1.8%，至2.12美元。
- Baird CutSalesforce，Inc.(紐約證券交易所代碼：CRM)目標價從200美元降至150美元。Baird分析師羅布·奧利弗將該股評級從強於大盤下調至中性。Salesforce股價在盤前交易中下跌0.9%，至129.37美元。
- 傑富瑞削減盧莫斯製藥公司(納斯達克股票代碼：Lumo)目標價從17美元下調至7美元。傑富瑞分析師Eun Yang將該股評級從買入下調至持有。Lumos Pharma股價週三下跌11.2%，收於4.46美元。
- 瑞銀股價上漲好時公司(紐約證券交易所代碼：HSY)目標價從244美元降至269美元。瑞銀分析師科迪·羅斯將該股評級從中性上調至買入。好時股價在盤前交易中上漲1.2%，至239.61美元。
Check out this: Why These Lululemon Analysts Have Boosted Their Price Targets Ahead Of Earnings
看看這個：為什麼這些lululemon分析師在盈利之前上調了目標價